Remifentanil Offset — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — 3-5 minutes
Remifentanil is an ultra-short-acting opioid metabolised by non-specific tissue and plasma esterases (not plasma cholinesterase). Its context-sensitive half-time is approximately 3-4 minutes regardless of infusion duration. Clinical effect dissipates within 3-5 minutes of stopping the infusion. This predictable offset is its key advantage but also requires that transitional analgesia (longer-acting opioid, multimodal analgesia, regional block) is established before or immediately upon discontinuation to prevent severe rebound pain.
Reference: RCOA – 2023 – Final FRCA curriculum: opioid pharmacology; Peck TE – 2014 – Pharmacology for Anaesthesia